Gene expression profiling of human colon cancer cells following inhibition of signal transduction by...
Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone
About this item
Full title
Author / Creator
CLARKE, P. A , HOSTEIN, I , BANERJI, U , DI STEFANO, F , MALONEY, A , WALTON, M , JUDSON, I and WORKMAN, P
Publisher
Basingstoke: Nature Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Basingstoke: Nature Publishing
Subjects
More information
Scope and Contents
Contents
A number of molecular therapeutic agents, derived from exploiting our knowledge of the oncogenic pathways that are frequently deregulated in cancer, are now entering clinical trials. One of these is the novel agent 17-allylamino-17-demethoxygeldanamycin that acts to inhibit the hsp90 molecular chaperone. Treatment of four human colon cancer cell li...
Alternative Titles
Full title
Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_72217996
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_72217996
Other Identifiers
ISSN
0950-9232
E-ISSN
1476-5594
DOI
10.1038/sj.onc.1203753
